Karyopharm Therapeutics

Home » Karyopharm Therapeutics

Secondary

Karyopharm Therapeutics

We are a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.

Symbol

KPTI

Last Closing Price
$14.75

Shares
9,100,000

Anticipated Date
TBD

Underwriters
J.P. Morgan, Jefferies, Leerink Partners, Canaccord Genuity, JMP Securities, H.C. Wainwright & Co., Baird

To view the prospectus for Karyopharm Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253